Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025

Q2 FY20 results · Jul–Sep 2019

Advanced Enzyme Technologies reported revenue from operations of ₹111.44 crore (up 8.0% from Q2 FY19) and net profit of ₹31.84 crore (up 23.1% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY20Q2 FY19YoYQ1 FY20QoQ
Revenue from operations111.44103.15+8.0%110.34+1.0%
Other income1.542.02−23.8%1.06+44.9%
Total income112.98105.17+7.4%111.40+1.4%
Profit before tax41.6036.63+13.6%47.47−12.4%
Net profit for the period31.8425.86+23.1%33.97−6.3%
Attributable to shareholders of the company30.9524.73+25.1%33.40−7.3%
EPS, basic (₹)2.772.21+25.3%2.99−7.4%
Net margin (%)28.625.130.8
Standalone · ₹ crore
ItemQ2 FY20Q2 FY19YoYQ1 FY20QoQ
Revenue from operations58.9158.57+0.6%58.51+0.7%
Other income1.103.01−63.4%1.64−32.7%
Total income60.0161.58−2.5%60.15−0.2%
Profit before tax14.2611.88+20.0%18.19−21.6%
Net profit for the period11.158.85+25.9%13.27−16.0%
EPS, basic (₹)1.000.80+25.0%1.19−16.0%
Net margin (%)18.915.122.7
Consolidated
Filed with BSE
04 Nov 2019, 10:38 IST
Board meeting
02 Nov 2019
Period
01 Jul 2019 to 30 Sep 2019
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
04 Nov 2019, 10:38 IST
Board meeting
02 Nov 2019
Period
01 Jul 2019 to 30 Sep 2019
Review status
Unaudited
Source
XBRL filing on BSE